(NASDAQ: SNY) Sanofi's forecast annual revenue growth rate of 7% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 9.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Sanofi's revenue in 2025 is $46,131,250,000.On average, 6 Wall Street analysts forecast SNY's revenue for 2025 to be $61,278,214,870,130, with the lowest SNY revenue forecast at $58,110,971,277,782, and the highest SNY revenue forecast at $65,508,007,400,366. On average, 6 Wall Street analysts forecast SNY's revenue for 2026 to be $65,853,654,617,354, with the lowest SNY revenue forecast at $61,518,686,910,632, and the highest SNY revenue forecast at $70,652,415,724,773.
In 2027, SNY is forecast to generate $71,667,621,559,954 in revenue, with the lowest revenue forecast at $68,274,460,890,219 and the highest revenue forecast at $76,155,967,732,442.